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Background: Oesophagectomy is a demanding operation that can be performed by different approaches
including open surgery or a combination of minimal access techniques. This systematic review and
network meta-analysis aimed to evaluate the clinical outcomes of open, minimally invasive and robotic
oesophagectomy techniques for oesophageal cancer.
Methods: A systematic literature search was conducted for studies reporting open oesophagectomy,
laparoscopically assisted oesophagectomy (LAO), thoracoscopically assisted oesophagectomy (TAO),
totally minimally invasive oesophagectomy (MIO) or robotic MIO (RAMIO) for oesophagectomy. A
network meta-analysis of intraoperative (operating time, blood loss), postoperative (overall complications,
anastomotic leaks, chyle leak, duration of hospital stay) and oncological (R0 resection, lymphadenectomy)
outcomes, and survival was performed.
Results: Ninety-eight studies involving 32 315 patients were included in the network meta-analysis (open
17 824, 55⋅2 per cent; LAO 1576, 4⋅9 per cent; TAO 2421 7⋅5 per cent; MIO 9558, 29⋅6 per cent; RAMIO
917, 2⋅8 per cent). Compared with open oesophagectomy, both MIO and RAMIO were associated with
less blood loss, significantly lower rates of pulmonary complications, shorter duration of stay and higher
lymph node yield. There were no significant differences between surgical techniques in surgical-site
infections, chyle leak, and 30- and 90-day mortality. MIO and RAMIO had better 1- and 5-year survival
rates respectively compared with open surgery.
Conclusion: Minimally invasive and robotic techniques for oesophagectomy are associated with reduced
perioperative morbidity and duration of hospital stay, with no compromise of oncological outcomes but
no improvement in perioperative mortality.
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Introduction
Oesophageal cancer remains a challenging disease
worldwide, with over 570 000 new cases in 20181. In
managing this disease, oesophagectomy remains the main-
stay of radical treatment with curative intent, with the
transthoracic approach the most commonly employed.
However, variation exists in surgical access techniques,
with approximately 40 per cent of oesophagectomies in
the UK now employing minimally invasive approaches2.
The most common procedure is hybrid oesophagectomy
where a laparoscopic gastric mobilization is performed
with an open thoracotomy; a thoracoscopic–open abdom-
inal hybrid procedure is uncommon. Less commonly
both thoracoscopic and laparoscopic techniques are used
in totally minimally invasive oesophagectomy (MIO).
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The use of robotic surgery for oesophagectomy is also
increasing.
Since the development of minimally invasive approaches
to oesophagectomy in the 1990s3–5, an evidence base has
been growing to suggest similar, if not better, results
in terms of morbidity and survival without compromis-
ing oncological benefit6,7. This includes various pairwise
meta-analyses of mainly non-randomized evidence8–18.
Many of these studies grouped MIO together with hybrid
procedures when comparing outcomes with those of open
oesophagectomy.
Given the limited evidence and understanding of the
potential benefits of different minimally invasive tech-
niques for oesophagectomy, this systematic review and net-
work meta-analysis aimed to compare oncological safety
and perioperative outcomes between these different surgi-
cal approaches and transthoracic oesophagectomy for can-
cer, along with impact on long-term survival.
Methods
Search strategy
This study was conducted according to PRISMA
guidelines19. A systematic and comprehensive search
was undertaken of the MEDLINE, Embase and Cochrane
Library databases, for studies published up to 25 February
2019. Search terms included the following, individually
or in combination: ‘oesophagectomy’ or ‘oesophagec-
tomy’ and ‘minimally invasive surgical procedures’ or
‘laparoscopy’ and ‘anastomotic leak’ or ‘postoperative
complications’ or ‘lymph nodes examined’ or ‘survival’
and ‘oesophageal cancer’ or ‘esophageal cancer’. The full
search strategy with all included search terms is shown
in Table S1 (supporting information). Manual scoping of
reference lists in recent reviews was also undertaken. The
protocol for this study was registered with the prospective
PROSPERO database (CRD42019125848).
Inclusion and exclusion criteria
Inclusion criteria were: comparative studies comparing any
approach to two- or three-stage transthoracic oesophagec-
tomy in human subjects with cancer of the oesophagus
or gastro-oesophageal junction, and studies published in
the English language. Exclusion criteria were: review arti-
cles; conference abstracts; studies with non-comparative
analyses of surgical approach including case reports;
studies reporting transhiatal or left thoracoabdomi-
nal approaches; studies using a non-gastric replacement
conduit; and studies reporting pharyngolaryngoesophagec-
tomy. After performing the literature search and removing
all duplicates, two researchers screened the remaining titles
and abstracts independently. Where a study was consid-
ered for inclusion, the full text was obtained. Discrepancies
between the judgement of the two primary researchers
were resolved through consensus with the other authors.
Additionally, during full-text review, authors of papers with
mixed groups of both hybrid and totally minimally invasive
techniques were contacted for separate data regarding
each technique. Where multiple studies analysed the same
data set or population, the most recent article was selected
unless different outcomes were reported.
Study outcomes
Outcome measures were: oncological – lymph node yield,
R0 resection margins; intraoperative – blood loss and
duration of operation; postoperative – duration of hospital
stay, 30- and 90-day mortality, overall, pulmonary, gas-
trointestinal and cardiac complications, anastomotic leak
and chyle leak, and 1-, 3- and 5-year overall survival. The
Esophageal Complications Consensus Group definitions
of complications were used20. R0 status was defined using
both College of American Pathologists21 and Royal Col-
lege of Pathology22 definitions: absence of residual tumour
at or within 1 mm of the resection margin respectively.
Data extraction
Two researchers extracted data on study characteristics
(author, year of publication, country, study interval, num-
ber of participants), patient characteristics (age, sex, BMI,
overall TNM stage, location of anastomosis (cervical, tho-
racic), anastomotic technique (stapled versus handsewn),
details of surgical approach and reported clinical outcomes.
Definitions
Open oesophagectomy was defined as oesophagectomy
carried out with laparotomy and open thoracotomy23,24.
MIO was defined as total MIO where laparoscopy was used
for the abdominal phase and thoracoscopy for the tho-
racic phase. Laparoscopically assisted hybrid oesophagec-
tomy (LAO) was defined as a laparoscopic abdominal
phase combined with open thoracotomy. Thoracoscopi-
cally assisted hybrid oesophagectomy (TAO) was defined
by an open abdominal phase combined with a thoraco-
scopic chest phase. Robotic MIO (RAMIO) was defined
as oesophagectomy where either the abdominal or tho-
racic phase was performed using a robotic platform, includ-
ing hybrid approaches25,26. Regardless of access approach,
two- and three-stage oesophagectomies, with intrathoracic
and cervical anastomoses respectively, were included, and
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 Hybrid procedures grouped with MIO n= 9
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 Hybrid procedures grouped with open operations n= 2
 No data, protocol only n= 2
 Non-comparative analysis n= 6
 Comparison of open procedures only n= 2





MIO, minimally invasive oesophagectomy.
a subgroup analysis was planned based on location of the
anastomosis.
Assessment of study quality
Methodological quality and standard of outcome reporting
was assessed in each study by two independent researchers.
Disagreements were settled through discussion between
these researchers or consensus with all authors. For cohort
studies, the Newcastle–Ottawa Scale27,28 was used to for-
mally assess quality, whereas the Cochrane risk-of-bias
tool29 was used for RCTs.
Statistical analysis
This systematic review and meta-analysis was conducted
in accordance with the recommendations of the Cochrane
Library and PRISMA guidelines, as reported previously30.
Dichotomous outcomes were compared using risk ratios
(RRs), produced by meta-analysis using random-effects
DerSimonian–Laird models. Heterogeneity between stud-
ies was assessed using the I2 value, with values of less than
25, 25–75 and over 75 per cent considered to represent low,
moderate and high degrees of heterogeneity respectively.
Both randomized and non-randomized studies were pooled
into a network meta-analysis comparing the above surgical
approaches with transthoracic oesophagectomy. For each
outcome, graphical representations of treatments (nodes)
and comparisons (lines) were mapped. Network maps were
then analysed for closed loops to be entered into network
analyses.
Networks were examined for the presence of incon-
sistency, allowing for comparisons between direct and
indirect treatment effects. Initially, this was assessed by
checking for overall inconsistency throughout the entire
© 2020 The Authors. www.bjsopen.com BJS Open 2020; 4: 787–803
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Table 1 Study- and patient-level characteristics of articles included in review












34 RCT Austria LAO versus open 26 n.r./n.r./n.r. 0 26 n.r. n.r. n.r. Some
concern
7 RCT France LAO versus open 207 3/63/141 0 207 n.r. n.r. n.r. Low
35 RCT China MIO versus open 144 11/90/43 n.r. n.r. n.r. n.r. n.r. High
36 RCT Netherlands,
Spain, Italy
MIO versus open 115 4/48/n.r. 75 32 n.r. n.r. n.r. Low
6 RCT Netherlands,
Spain, Italy
MIO versus open 115 4/48/63 75 32 n.r. n.r. n.r. Low
37 RCT China MIO versus open 114 0/0/0 114 0 114 0 0 High
38 RCT China MIO versus TAO 68 7/39/22 68 0 36 n.r. n.r. High
39 RCT Netherlands RAMIO versus
open
109 1/13/55 106 0 106 0 0 Low
40 PCS Serbia LAO versus open 88 0/34/54 0 88 n.r. n.r. n.r. 7
41 PCS UK LAO versus open 70 n.r. 0 70 n.r. n.r. n.r. 6
42 PCS UK MIO versus LAO
versus open
75 n.r. 0 75 26 n.r. n.r. 6
43 PCS UK MIO versus LAO
versus open
86 n.r. n.r. n.r. n.r. n.r. n.r. 6
44 PCS Sweden MIO versus open 366 n.r. 261 105 n.r. n.r. n.r. 8
45 PCS Taiwan MIO versus open 190 15/91/83 190 0 99 53 38 8
46 PCS UK MIO versus open 106 0/4/46 0 106 1 0 105 5
47 PCS Korea MIO versus TAO 98 0/24/74 0 98 0 0 98 6
48 PCS Japan MIO versus TAO
versus LAO
versus open
210 26/133/51 198 12 n.r. n.r. n.r. 6
49 PCS Australia TAO versus open 487 0/43/355 n.r. 110 n.r. n.r. n.r. 8
50 PCS Japan TAO versus open 84 n.r. n.r. n.r. n.r. n.r. n.r. 6
51 RCS Japan MIO versus TAO 315 n.r. 315 0 315 0 0 8
52 RCS Japan MIO versus TAO 64 6/14/44 64 0 n.r. n.r. n.r. 8
53 PCS Germany LAO versus MIO 60 n.r. 0 60 0 0 60 8
54 RCS Sweden LAO versus MIO 173 4/28/6 n.r. n.r. n.r. n.r. n.r. 6
55 RCS Japan LAO versus MIO 105 18/67/17 n.r. n.r. 39 n.r. n.r. 7
56 RCS Japan LAO versus open 216 41/108/67 216 0 0 0 216 8
57 RCS South Korea LAO versus open 115 n.r./36/79 0 115 3 4 108 7
58 RCS China LAO versus open 685 n.r. 0 685 n.r. n.r. n.r. 8
59 RCS Germany LAO versus open 120 0/16/104 0 120 n.r. n.r. n.r. 8
60 RCS France LAO versus open 140 0/123/17 0 140 n.r. n.r. n.r. 8
61 RCS France LAO versus open 280 0/110/170 0 280 n.r. n.r. n.r. 8
62 RCS Italy LAO versus open 68 n.r. 13 55 n.r. n.r. n.r. 8
63 RCS UK MIO versus LAO
versus open
334 0/22/122 n.r. n.r. 67 n.r. n.r. 8
64 RCS China MIO versus
LAO/TAO versus
open
548 154/331/63 548 0 n.r. n.r. n.r. 6
65 RCS Pakistan MIO versus
LAO/TAO versus
open
216 n.r. n.r. n.r. n.r. n.r. n.r. 8
66 RCS Japan MIO versus open 98 8/60/30 9 89 12 0 84 7
67 RCS Japan MIO versus open 171 3/44/45 171 0 0 0 171 7
68 RCS Japan MIO versus open 130 n.r. 65 65 n.r. n.r. n.r. 8
69 RCS China MIO versus open 63 n.r. 0 63 n.r. n.r. n.r. 8
70 RCS China MIO versus open 228 3/130/95 n.r. n.r. n.r. n.r. n.r. 7
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71 RCS China MIO versus open 269 0/191/78 0 269 n.r. n.r. n.r. 7
72 RCS China MIO versus open 221 20/154/47 n.r. n.r. n.r. n.r. n.r. 7
73 RCS USA MIO versus open 39 n.r. 39 0 n.r. n.r. n.r. 6
74 RCS China MIO versus open 257 54/169/34 257 0 62 0 195 8
75 RCS Netherlands MIO versus open 866 16/189/517 563 303 n.r. n.r. n.r. 8
76 RCS China MIO versus open 183 24/118/41 183 0 n.r. n.r. n.r. 7
77 RCS China MIO versus open 80 7/56/17 80 0 0 80 0 6
78 RCS Finland MIO versus open 153 n.r. 0 153 79 0 73 7
79 RCS USA MIO versus open 168 n.r. n.r. n.r. n.r. n.r. n.r. 6
80 RCS USA MIO versus open 130 0/5/72 n.r. n.r. n.r. n.r. n.r. 7
81 RCS USA MIO versus open 114 n.r. 0 114 0 0 114 8
82 RCS Japan MIO versus open 62 9/34/9 62 0 n.r. n.r. n.r. 7
83 RCS China MIO versus open 113 0/113/0 113 0 0 0 113 6
84 RCS China MIO versus open 230 94/115/21 230 0 n.r. n.r. n.r. 7
85 RCS Finland, Sweden MIO versus open 1614 n.r. n.r. n.r. n.r. n.r. n.r. 6
86 RCS USA MIO versus open 146 0/3/0 138 8 n.r. n.r. n.r. 8
87 RCS UK MIO versus open 80 n.r./n.r./10 49 31 n.r. n.r. n.r. 6
88 RCS China MIO versus open 379 n.r. 0 379 0 0 379 7
89 RCS China MIO versus open 118 7/74/37 118 0 n.r. n.r. n.r. 8
90 RCS China MIO versus open 447 n.r. 348 99 n.r. n.r. n.r. 7
91 RCS Netherlands,
Spain, Italy
MIO versus open 575 n.r. n.r. n.r. n.r. n.r. n.r. 7
92 RCS USA MIO versus open 4047 n.r. n.r. n.r. n.r. n.r. n.r. 8
93 RCS China MIO versus open 118 0/49/69 n.r. n.r. n.r. n.r. n.r. 7
94 RCS China MIO versus open 194 35/87/72 n.r. n.r. n.r. n.r. n.r. 8
95 RCS UK MIO versus open 7502 n.r. n.r. n.r. n.r. n.r. n.r. 8
96 RCS Belgium MIO versus open 166 n.r. 166 0 n.r. n.r. n.r. 7
97 RCS Japan MIO versus open 92 6/60/26 92 0 n.r. n.r. n.r. 8
98 RCS China MIO versus open 174 15/127/32 174 0 n.r. n.r. n.r. 7
99 RCS China MIO versus open 162 n.r. n.r. n.r. n.r. n.r. n.r. 7
100 RCS China MIO versus open 407 25/290/92 n.r. n.r. n.r. n.r. n.r. 7
101 RCS China MIO versus TAO 172 54/73/45 172 0 n.r. n.r. n.r. 8
102 RCS Japan MIO versus TAO 64 7/23/34 64 0 64 0 0 6
103 RCS Italy MIO versus TAO 160 6/29/125 80 80 0 160 0 8
104 RCS China MIO versus TAO
versus LAO
versus open
109 16/59/34 n.r. n.r. n.r. n.r. n.r. 7
105 RCS Japan MIO versus TAO
versus open
242 36/137/69 242 0 n.r. n.r. n.r. 8
106 RCS Japan MIO versus TAO
versus open
185 33/85/67 170 15 97 0 88 7
107 RCS China MIO versus TAO
versus open
138 23/n.r./n.r. 138 0 n.r. n.r. n.r. 6
108 RCS Thailand MIO versus TAO
versus open
83 17/41/25 83 0 n.r. n.r. n.r. 7
109 RCS Australia MIO versus TAO
versus open
446 10/84/262 n.r. n.r. n.r. n.r. n.r. 6
110 RCS Australia MIO versus TAO
versus open
858 15/78/524 858 0 n.r. n.r. n.r. 7
111 RCS Taiwan RAMIO versus MIO 68 20/34/14 68 0 n.r. n.r. n.r. 8
112 RCS South Korea RAMIO versus MIO 105 15/24/66 56 35 n.r. n.r. n.r. 6
113 RCS China RAMIO versus MIO 54 4/33/n.r. 54 0 0 0 54 8
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114 RCS USA RAMIO versus MIO 37 n.r. 37 0 0 24 0 7
115 RCS China RAMIO versus MIO 84 0/84/0 84 0 84 0 0 7
116 RCS USA RAMIO versus MIO
versus open
1707 n.r. n.r. n.r. n.r. n.r. n.r. 8
117 RCS South Korea RAMIO versus
open
247 n.r. 247 0 n.r. n.r. n.r. 8
118 RCS Japan RAMIO versus
open
60 2/30/28 n.r. n.r. n.r. n.r. n.r. 7
119 RCS China TAO versus open 78 9/48/21 78 0 n.r. n.r. n.r. 7
120 RCS China TAO versus open 108 20/88/0 n.r. n.r. n.r. n.r. n.r. 7
121 RCS Japan TAO versus open 257 32/143/82 n.r. n.r. n.r. n.r. n.r. 9
122 RCS Japan TAO versus open 59 9/31/19 59 0 59 0 0 5
123 RCS South Korea TAO versus open 84 n.r./61/23 14 70 0 0 84 8
124 RCS Japan TAO versus open 51 5/34/12 51 0 n.r. n.r. n.r. 6
125 RCS Japan TAO versus open 149 23/85/41 149 0 n.r. n.r. n.r. 7
126 RCS Taiwan TAO versus open 129 20/63/36 129 0 n.r. n.r. n.r. 6
127 RCS Japan TAO versus open 329 52/193/84 n.r. n.r. n.r. n.r. n.r. 7
128 RCS Hong Kong TAO versus open 81 8/61/9 18 63 18 n.r. n.r. 7
129 RCS China TAO versus open 178 26/68/84 n.r. n.r. n.r. n.r. n.r. 8
*For RCTs, the risk of bias was determined as low, high or of some concern. U, upper; M, middle; L, lower; NOS, Newcastle–Ottawa Scale; LAO,
laparoscopically assisted oesophagectomy; n.r., not reported; MIO, minimally invasive oesophagectomy; TAO, thoracoscopically assisted oesophagectomy;
RAMIO, robotic minimally invasive oesophagectomy; PCS, prospective cohort study; RCS, retrospective cohort study.
network. A further check was then performed by fitting
node side-splitting models to identify loop inconsistency,
within all three-way treatment comparison loops, as
described by Dias and colleagues31. If P exceeded 0⋅050,
representing acceptance of the null hypothesis, consistency
was assumed and networks were entered into consistency
modelling. Consistency models used a restricted maximum
likelihood model, generating network forest plots. Hetero-
geneity was examined by calculation of τ2. These were sup-
plemented with interval plots of pooled effect estimates.
Surgical approaches were then ranked using P-scores,
whereby a P-score greater than 0⋅900 was considered to
indicate the best technique with high probability. Subgroup
analyses were conducted according to location of anasto-
moses, either cervical or thoracic, and for a more recent
time cohort (2010 onwards). Statistical analyses for net-
work meta-analysis were undertaken using R version 3.2.1
(R Foundation for Statistical Computing, Vienna, Austria),
with the netmeta packages, as described previously32,33.
Results
Study characteristics
The review identified 98 studies6,7,34–129 comparing sur-
gical approaches for oesophagectomy, involving 32 315
patients (Fig. 1). Of these, 55⋅2 per cent (17 824), 4⋅9 per
cent (1576), 7⋅5 per cent (2421), 29⋅6 per cent (9558)
and 2⋅8 per cent (917) were open oesophagectomy, LAO,
TAO, MIO and RAMIO respectively. Study character-
istics are presented in Table 1. The majority of studies
were non-randomized (90). Eight studies were RCTs. Most
studies compared two different oesophagectomy tech-
niques; 14 compared at least three different techniques.
Studies involving open oesophagectomy (82) and MIO
(71) were the most commonly reported. TAO was ana-
lysed in 30 studies, of which 13 compared it with open
oesophagectomy only, seven with MIO only, and ten with
both open and MIO. LAO was compared with open surgery
in 12 articles, whereas three analysed it against MIO. There
were eight papers comparing RAMIO with MIO (5) and
open oesophagectomy (3). Subgroup analyses by location
of anastomoses are presented in Tables S2–S5 (supporting
information).
Intraoperative outcomes
Table 2 shows the results of pairwise comparisons between
intraoperative outcomes, and network maps are presented
in Fig. S1 (supporting information). Duration of opera-
tion was reported in 77 studies. Open surgery resulted
in significantly shorter operating times than MIO (mean
© 2020 The Authors. www.bjsopen.com BJS Open 2020; 4: 787–803
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Table 2 Summary of intraoperative outcomes of overall network meta-analysis
Duration of surgery (min) Blood loss (ml)
No. of studies Mean difference P No. of studies Mean difference P
Open versus TAO 15 –21 (–37, –5) 0⋅011 16 91 (49, 133) <0⋅001
Open versus LAO 13 0 (–19, 19) 0⋅997 4 84 (16, 153) 0⋅016
Open versus MIO 37 –37 (–48, –26) <0⋅001 36 173 (146, 200) <0⋅001
Open versus RAMIO 3 –75 (–104, –46) <0⋅001 3 163 (99, 226) <0⋅001
MIO versus TAO 12 16 (–1, 33) 0⋅063 12 –82 (–125, –39) <0⋅001
MIO versus LAO 5 37 (16, 58) <0⋅001 4 –88 (–158, –20) 0⋅012
MIO versus RAMIO 4 –38 (–67, –9) 0⋅011 5 –10 (–73, 52) 0⋅750
LAO versus TAO 1 –21 (–45, 3) 0⋅090 1 7 (–71, 85) 0⋅867
RAMIO versus TAO 0 54 (21, 86) 0⋅001 0 –72 (–145, 2) 0⋅056
RAMIO versus LAO 0 75 (40, 109) <0⋅001 0 –78 (–170, 13) 0⋅093
Values in parentheses are 95 per cent confidence intervals. TAO, thoracoscopically assisted oesophagectomy; LAO, laparoscopically assisted oesophagec-
tomy; MIO, minimally invasive oesophagectomy; RAMIO, robotic minimally invasive oesophagectomy.
Table 3 Ranking of surgical techniques for intraoperative, oncological and postoperative outcomes according to P-scores
Rank
1 2 3 4 5
Duration of operation Open (P = 0⋅874) LAO (P = 0⋅863) TAO (P = 0⋅505) MIO (P = 0⋅257) RAMIO (P = 0⋅002)
Blood loss MIO (P = 0⋅905) RAMIO (P = 0⋅825) TAO (P = 0⋅399) LAO (P = 0⋅369) Open (P = 0⋅002)
Overall complications RAMIO (P = 0⋅872) LAO (P = 0⋅672) MIO (P = 0⋅657) TAO (P = 0⋅199) Open (P = 0⋅101)
Pulmonary complications MIO (P = 0⋅872) TAO (P = 0⋅632) RAMIO (P = 0⋅550) LAO (P = 0⋅414) Open (P = 0⋅031)
Cardiac complications RAMIO (P = 0⋅987) LAO (P = 0⋅688) MIO (P = 0⋅548) Open (P = 0⋅219) TAO (P = 0⋅058)
Anastomotic leak TAO (P = 0⋅810) MIO (P = 0⋅775) Open (P = 0⋅443) RAMIO (P = 0⋅367) LAO (P = 0⋅106)
Wound/diaphragm complications TAO (P = 0⋅885) RAMIO (P = 0⋅661) Open (P = 0⋅434) MIO (P = 0⋅295) LAO (P = 0⋅226)
Gastrointestinal complications MIO (P = 0⋅854) TAO (P = 0⋅684) Open (P = 0⋅478) RAMIO (P = 0⋅347) LAO (P = 0⋅136)
Chyle leak LAO (P = 0⋅704) Open (P = 0⋅659) MIO (P = 0⋅558) TAO (P = 0⋅332) RAMIO (P = 0⋅247)
Duration of hospital stay RAMIO (P = 0⋅911) MIO (P = 0⋅707) TAO (P = 0⋅625) LAO (P = 0⋅229) Open (P = 0⋅028)
30-day mortality Open (P = 0⋅697) MIO (P = 0⋅562) LAO (P = 0⋅538) TAO (P = 0⋅368) RAMIO (P = 0⋅334)
90-day mortality LAO (P = 0⋅779) MIO (P = 0⋅541) Open (P = 0⋅417) RAMIO (P = 0⋅264) –
Lymph nodes examined RAMIO (P = 0⋅969) MIO (P = 0⋅698) TAO (P = 0⋅418) Open (P = 0⋅253) LAO (P = 0⋅162)
R0 resection RAMIO (P = 0⋅729) MIO (P = 0⋅699) TAO (P = 0⋅629) LAO (P = 0⋅315) Open (P = 0⋅129)
1-year survival TAO (P = 0⋅861) MIO (P = 0⋅682) LAO (P = 0⋅544) Open (P = 0⋅218) RAMIO (P = 0⋅194)
3-year survival TAO (P = 0⋅751) LAO (P = 0⋅551) RAMIO (P = 0⋅544) MIO (P = 0⋅436) Open (P = 0⋅219)
5-year survival RAMIO (P = 0⋅949) TAO (P = 0⋅609) MIO (P = 0⋅506) LAO (P = 0⋅360) Open (P = 0⋅076)
LAO, laparoscopically assisted oesophagectomy; TAO, thoracoscopically assisted oesophagectomy; MIO, minimally invasive oesophagectomy; RAMIO,
robotic minimally invasive oesophagectomy.
difference (MD) 37 min; P < 0⋅001), RAMIO (MD 75 min;
P < 0⋅001) and TAO (MD 21 min; P = 0⋅011) (Table 2).
Open surgery had the shortest operating time, with a high
probability, followed by hybrid operations then MIO and
RAMIO (Table 3). Open oesophagectomy was ranked first
for cervical anastomosis, whereas LAO was ranked first
for thoracic anastomosis (Tables S2 and S3, supporting
information).
Blood loss was reported in 65 studies. Open oesophagec-
tomy had significantly higher blood loss than TAO (MD
91 ml; P < 0⋅001), LAO (MD 84 ml; P = 0⋅016), RAMIO
(MD 163 ml; P < 0⋅001) and MIO (MD 173 ml; P= 0⋅001).
MIO was ranked first for lowest blood loss, with a high
probability, followed by RAMIO (Table 3). MIO was ranked
first for both cervical and thoracic anastomosis, followed by
RAMIO (Tables S2 and S3, supporting information).
Postoperative outcomes
The results of all pairwise comparisons of each surgical
approach for postoperative complications are shown in
Tables 4 and 5, and network maps in Fig. S2 (supporting
© 2020 The Authors. www.bjsopen.com BJS Open 2020; 4: 787–803
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
794 K. Siaw-Acheampong, S. K. Kamarajah, R. Gujjuri, J. R. Bundred, P. Singh and E. A. Griffiths
Table 4 Summary of postoperative complications in overall network meta-analysis
No. of
studies Risk ratio P
No. of
studies Risk ratio P
No. of
studies Risk ratio P
Overall complications Pulmonary complications Cardiac complications
Open versus TAO 6 1⋅07 (0⋅72, 1⋅58) 0⋅742 15 1⋅66 (1⋅17, 2⋅35) 0⋅004 7 0⋅86 (0⋅62, 1⋅19) 0⋅356
Open versus LAO 9 1⋅59 (1⋅11, 2⋅22) 0⋅010 15 1⋅39 (0⋅97, 2⋅00) 0⋅073 8 1⋅41 (0⋅95, 2⋅08) 0⋅089
Open versus MIO 17 1⋅54 (1⋅22, 1⋅96) <0⋅001 40 1⋅92 (1⋅54, 2⋅38) <0⋅001 28 1⋅19 (1⋅03, 1⋅37) 0⋅015
Open versus RAMIO 1 2⋅20 (0⋅98, 4⋅97) 0⋅057 3 0⋅87 (0⋅82, 0⋅92) 0⋅001 2 2⋅87 (1⋅43, 5⋅75) 0⋅003
MIO versus TAO 3 0⋅69 (0⋅46, 1⋅04) 0⋅079 11 0⋅86 (0⋅60, 1⋅24) 0⋅415 6 0⋅72 (0⋅52, 1⋅00) 0⋅051
MIO versus LAO 2 1⋅02 (0⋅68, 1⋅52) 0⋅931 7 0⋅72 (0⋅49, 1⋅09) 0⋅110 2 1⋅18 (0⋅78, 1⋅79) 0⋅431
MIO versus RAMIO 1 1⋅42 (0⋅63, 3⋅24) 0⋅401 5 0⋅81 (0⋅43, 1⋅51) 0⋅498 2 2⋅41 (1⋅19, 4⋅89) 0⋅015
LAO versus TAO 0 0⋅68 (0⋅40, 1⋅14) 0⋅139 1 1⋅19 (0⋅72, 1⋅94) 0⋅498 0 0⋅61 (0⋅37, 1⋅02) 0⋅057
RAMIO versus TAO 0 0⋅49 (0⋅20, 1⋅19) 0⋅112 0 1⋅07 (0⋅53, 2⋅17) 0⋅854 0 0⋅30 (0⋅14, 0⋅64) 0⋅002
RAMIO versus LAO 0 0⋅71 (0⋅30, 1⋅72) 0⋅457 0 0⋅90 (0⋅44, 1⋅85) 0⋅777 0 0⋅49 (0⋅22, 1⋅09) 0⋅081
Anastomotic leak Surgical-site infection Gastrointestinal complications
Open versus TAO 15 1⋅22 (0⋅88, 1⋅73) 0⋅237 1 6⋅09 (0⋅82, 45⋅06) 0⋅077 15 1⋅11 (0⋅79, 1⋅56) 0⋅544
Open versus LAO 14 0⋅72 (0⋅47, 1⋅11) 0⋅136 5 0⋅70 (0⋅23, 2⋅17) 0⋅540 15 0⋅75 (0⋅51, 1⋅11) 0⋅160
Open versus MIO 39 1⋅18 (0⋅93, 1⋅49) 0⋅170 12 0⋅83 (0⋅43, 1⋅64) 0⋅599 41 1⋅20 (0⋅96, 1⋅49) 0⋅109
Open versus RAMIO 3 0⋅88 (0⋅44, 1⋅79) 0⋅730 1 3⋅00 (0⋅10, 94⋅13) 0⋅532 3 0⋅85 (0⋅40, 1⋅79) 0⋅670
MIO versus TAO 13 1⋅04 (0⋅74, 1⋅46) 0⋅829 1 7⋅29 (0⋅95, 56⋅01) 0⋅056 13 0⋅93 (0⋅66, 1⋅31) 0⋅663
MIO versus LAO 8 0⋅61 (0⋅39, 0⋅95) 0⋅030 2 0⋅84 (0⋅27, 2⋅63) 0⋅771 9 0⋅63 (0⋅42, 0⋅94) 0⋅024
MIO versus RAMIO 5 0⋅75 (0⋅37, 1⋅54) 0⋅430 0 3⋅59 (0⋅11, 120⋅31) 0⋅475 5 0⋅71 (0⋅34, 1⋅50) 0⋅369
LAO versus TAO 2 1⋅69 (1⋅01, 2⋅86) 0⋅048 0 8⋅66 (0⋅90, 83⋅54) 0⋅062 0 1⋅47 (0⋅90, 2⋅42) 0⋅127
RAMIO versus TAO 0 1⋅39 (0⋅64, 3⋅00) 0⋅406 0 2⋅03 (0⋅04, 109⋅19) 0⋅728 0 1⋅31 (0⋅58, 2⋅93) 0⋅517
RAMIO versus LAO 0 0⋅82 (0⋅36, 1⋅85) 0⋅631 0 0⋅23 (0⋅01, 9⋅09) 0⋅433 2 0⋅88 (0⋅39, 2⋅04) 0⋅778
Chyle leak Duration of hospital stay (days)
Open versus TAO 9 0⋅81 (0⋅49, 1⋅32) 0⋅391 13 2⋅77 (1⋅60, 3⋅93)* <0⋅001
Open versus LAO 7 1⋅12 (0⋅51, 2⋅44) 0⋅780 12 0⋅87 (0⋅53, 2⋅26)* 0⋅223
Open versus MIO 22 0⋅95 (0⋅71, 1⋅28) 0⋅750 38 3⋅00 (2⋅30, 3⋅70)* <0⋅001
Open versus RAMIO 1 0⋅69 (0⋅31, 1⋅54) 0⋅368 2 3⋅85 (1⋅80, 5⋅71)* <0⋅001
MIO versus TAO 5 0⋅84 (0⋅50, 1⋅43) 0⋅531 12 –0⋅23 (–1⋅43, 1⋅00)* 0⋅706
MIO versus LAO 3 1⋅18 (0⋅52, 2⋅63) 0⋅700 4 –2⋅13 (–3⋅64, –0⋅63)* 0⋅005
MIO versus RAMIO 2 0⋅73 (0⋅32, 1⋅68) 0⋅454 3 0⋅85 (–1⋅01, 2⋅70)* 0⋅371
LAO versus TAO 0 0⋅72 (0⋅29, 1⋅81) 0⋅485 1 1⋅90 (0⋅12, 3⋅69)* 0⋅036
RAMIO versus TAO 0 1⋅16 (0⋅46, 2⋅96) 0⋅754 0 –1⋅08 (–3⋅23, 1⋅07)* 0⋅326
RAMIO versus LAO 0 1⋅61 (0⋅53, 5⋅00) 0⋅402 0 –2⋅98 (–5⋅29, –0⋅67)* 0⋅011
Values in parentheses are 95 per cent confidence intervals. *Mean difference. TAO, thoracoscopically assisted oesophagectomy; LAO, laparoscopically
assisted oesophagectomy; MIO, minimally invasive oesophagectomy; RAMIO, robotic minimally invasive oesophagectomy.
information). There were no significant differences
between surgical approaches for surgical-site infections,
chyle leak and 30- or 90-day mortality.
Overall complications
Overall complications were reported in 39 studies. LAO
(RR 0⋅63; P= 0⋅010) and MIO (RR 0⋅65; P < 0⋅001) had
significantly lower rates of overall complications than
open surgery (Table 4). RAMIO was ranked best for over-
all complications (Table 3). MIO was ranked first for
cervical anastomosis, whereas RAMIO was ranked first
for thoracic anastomosis (Tables S3 and S4, supporting
information).
Pulmonary complications
Pulmonary complications were reported in 79 studies.
MIO (RR 0⋅52; P < 0⋅001) and TAO (RR 0⋅60; P= 0⋅004)
were associated with significantly lower rates of pul-
monary complications than open surgery. MIO was
ranked the best technique in terms of pulmonary com-
plications overall (Table 3), and in subgroups of cervical
and thoracic anastomoses (Tables S3 and S4, supporting
information).
Cardiac complications
Cardiac complications were reported in 46 studies.
RAMIO (RR 0⋅35; P= 0⋅003) and MIO (RR 0⋅84;
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Table 5 Summary of postoperative mortality and survival in overall network meta-analysis
No. of
studies Risk ratio P
No. of
studies Risk ratio P
No. of
studies Risk ratio P
30-day mortality 90-day mortality 1-year survival
Open versus TAO 2 0⋅62 (0⋅14, 2⋅67) 0⋅517 9 1⋅62 (1⋅01, 2⋅58) 0⋅043
Open versus LAO 7 0⋅84 (0⋅27, 2⋅63) 0⋅768 0 1⋅47 (0⋅58, 3⋅70) 0⋅410 9 1⋅23 (0⋅79, 1⋅92) 0⋅361
Open versus MIO 20 0⋅87 (0⋅46, 1⋅64) 0⋅672 5 1⋅08 (0⋅66, 1⋅75) 0⋅772 26 1⋅35 (1⋅02, 1⋅79) 0⋅035
Open versus RAMIO 2 0⋅57 (0⋅12, 2⋅61) 0⋅469 2 0⋅87 (0⋅45, 1⋅70) 0⋅683 2 0⋅86 (0⋅40, 1⋅86) 0⋅714
MIO versus TAO 3 0⋅71 (0⋅17, 2⋅94) 0⋅634 2 1⋅20 (0⋅71, 2⋅03) 0⋅506
MIO versus LAO 2 0⋅97 (0⋅28, 3⋅33) 0⋅958 0 1⋅37 (0⋅48, 4⋅00) 0⋅552 3 0⋅92 (0⋅56, 1⋅52) 0⋅749
MIO versus RAMIO 3 0⋅65 (0⋅15, 2⋅96) 0⋅582 3 0⋅81 (0⋅42, 1⋅58) 0⋅535 2 0⋅64 (0⋅29, 1⋅39) 0⋅267
LAO versus TAO 0 0⋅73 (0⋅12, 4⋅52) 0⋅736 0 1⋅31 (0⋅69, 2⋅51) 0⋅420
RAMIO versus TAO 0 1⋅08 (0⋅14, 8⋅34) 0⋅940 0 1⋅88 (0⋅77, 4⋅61) 0⋅167
RAMIO versus LAO 0 1⋅47 (0⋅23, 10⋅00) 0⋅682 0 1⋅69 (0⋅54, 5⋅26) 0⋅364 0 1⋅43 (0⋅50, 3⋅45) 0⋅436
3-year survival 5-year survival
Open versus TAO 8 1⋅38 (0⋅86, 2⋅22) 0⋅184 7 1⋅49 (0⋅94, 2⋅34) 0⋅086
Open versus LAO 8 1⋅19 (0⋅76, 1⋅85) 0⋅453 5 1⋅20 (0⋅76, 1⋅89) 0⋅428
Open versus MIO 23 1⋅10 (0⋅83, 1⋅45) 0⋅514 18 1⋅33 (1⋅00, 1⋅79) 0⋅051
Open versus RAMIO 2 1⋅20 (0⋅58, 2⋅48) 0⋅636 0 4⋅00 (1⋅05, 15⋅33) 0⋅042
MIO versus TAO 1 1⋅26 (0⋅73, 2⋅15) 0⋅409 1 1⋅11 (0⋅66, 1⋅89) 0⋅711
MIO versus LAO 2 1⋅08 (0⋅65, 1⋅79) 0⋅790 2 0⋅90 (0⋅55, 1⋅49) 0⋅697
MIO versus RAMIO 2 1⋅09 (0⋅53, 2⋅26) 0⋅827 1 3⋅00 (0⋅81, 11⋅12) 0⋅100
LAO versus TAO 0 1⋅16 (0⋅61, 2⋅23) 0⋅667 0 1⋅23 (0⋅65, 2⋅35) 0⋅539
RAMIO versus TAO 0 1⋅15 (0⋅48, 2⋅72) 0⋅765 0 0⋅37 (0⋅09, 1⋅53) 0⋅170
RAMIO versus LAO 0 0⋅99 (0⋅42, 2⋅27) 0⋅983 0 0⋅30 (0⋅07, 1⋅22) 0⋅093
Values in parentheses are 95 per cent confidence intervals. TAO, thoracoscopically assisted oesophagectomy; LAO, laparoscopically assisted oesophagec-
tomy; MIO, minimally invasive oesophagectomy; RAMIO, robotic minimally invasive oesophagectomy.
P= 0⋅015) were associated with significantly lower rates
of cardiac complications than open oesophagectomy.
RAMIO had significantly lower rates of cardiac complica-
tions compared with TAO (RR 0⋅30; P= 0⋅002) and MIO
(RR 0⋅42; P= 0⋅015). RAMIO was ranked first for cardiac
complications (Table 3).
Anastomotic leaks
Anastomotic leak was reported in 74 studies. LAO was
significantly associated with a higher rate of anastomotic
leak than TAO (RR 1⋅69; P= 0⋅048) and MIO (RR 1⋅63;
P= 0⋅030) (Table 4). TAO was ranked first for anastomotic
leak (Table 3). In terms of anastomotic leakage, TAO was
ranked first for thoracic anastomosis, whereas RAMIO was
ranked first for cervical anastomosis (Tables S3 and S4,
supporting information).
Duration of hospital stay
Length of hospital stay was reported in 72 studies. MIO
(MD 3⋅00 days; P < 0⋅001), RAMIO (MD 3⋅85 days;
P < 0⋅001) and TAO (MD 2⋅77 days; P < 0⋅001) were asso-
ciated with significantly shorter duration of stay compared
with open oesophagectomy. RAMIO (MD 2⋅98 days;
P= 0⋅011) and TAO (MD 1⋅90 days; P= 0⋅036) were also
associated with significantly shorter hospital stay than
LAO. RAMIO was ranked first, with a high probability,
followed by MIO (Table 3).
Overall survival
One-year overall survival was reported in 53 studies. The
open approach was associated with significantly lower
1-year survival than TAO (RR 1⋅62; P= 0⋅043) and MIO
(RR 1⋅35; P= 0⋅035) (Table 5). Overall, TAO was ranked
first for 1-year survival (Table 3). However, MIO and
LAO were ranked first for cervical and thoracic anasto-
mosis respectively (Tables S3 and S4, supporting infor-
mation). Three-year overall survival was reported in 46
studies. There were no significant differences in out-
comes between any techniques. Five-year overall survival
was reported in 34 studies. Open oesophagectomy was
associated with significantly lower 5-year survival than
RAMIO (RR 4⋅00; P= 0⋅042) (Table 5). Overall, RAMIO
was ranked the best technique, with high probability
(Table 3). A sensitivity analysis for 1- and 5-year sur-
vival including studies from 2010 onwards yielded similar
results.
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Table 6 Summary of oncological outcomes of overall network meta-analysis
Lymph nodes examined Negative resection margins (R0)
Comparison No. of studies Mean difference P No. of studies Risk ratio P
Open versus TAO 17 –0⋅37 (–1⋅79, 1⋅05) 0⋅606 6 0⋅75 (0⋅51, 1⋅11) 0⋅150
Open versus LAO 11 0⋅42 (–1⋅35, 2⋅20) 0⋅640 7 0⋅93 (0⋅57, 1⋅49) 0⋅756
Open versus MIO 34 –1⋅06 (–2⋅05, –0⋅08) 0⋅035 14 0⋅73 (0⋅60, 0⋅89) 0⋅002
Open versus RAMIO 2 –3⋅11 (–5⋅80, –0⋅41) 0⋅024 1 0⋅70 (0⋅44, 1⋅10) 0⋅121
MIO versus TAO 11 0⋅69 (–0⋅82, 2⋅20) 0⋅370 4 1⋅03 (0⋅70, 1⋅53) 0⋅885
MIO versus LAO 3 1⋅49 (0⋅49, 3⋅46) 0⋅014 0 1⋅27 (0⋅75, 2⋅13) 0⋅369
MIO versus RAMIO 6 –2⋅04 (–4⋅65, 0⋅57) 0⋅125 2 0⋅96 (0⋅60, 1⋅51) 0⋅844
LAO versus TAO 1 –0⋅80 (–3⋅04, 1⋅45) 0⋅487 0 0⋅81 (0⋅44, 1⋅50) 0⋅505
RAMIO versus TAO 0 2⋅73 (–0⋅23, 5⋅69) 0⋅070 0 1⋅08 (0⋅60, 1⋅93) 0⋅801
RAMIO versus LAO 0 3⋅53 (0⋅33, 6⋅73) 0⋅031 0 1⋅33 (0⋅68, 2⋅56) 0⋅399
Values in parentheses are 95 per cent confidence intervals. TAO, thoracoscopically assisted oesophagectomy; LAO, laparoscopically assisted oesophagec-
tomy; MIO, minimally invasive oesophagectomy; RAMIO, robotic minimally invasive oesophagectomy.
Oncological outcomes
Lymph nodes examined
The results of all pairwise comparisons of oncological out-
comes for each surgical approach technique are shown in
Table 6, and network maps in Fig. S3 (supporting informa-
tion). Lymph node assessment was reported in 77 studies.
LAO (mean difference 3⋅53; P= 0⋅031) and open surgery
(mean difference 3⋅11; P= 0⋅024) were associated with sig-
nificantly lower numbers of lymph nodes examined than
RAMIO. RAMIO was ranked as the best technique, with
high probability, followed by MIO (Table 3).
R0 resection
R0 resections were reported in 40 studies. MIO was associ-
ated with higher rates of R0 resection (RR 1⋅37; P= 0⋅002)
than open surgery. RAMIO was ranked first, followed by
MIO (Table 3).
Discussion
This network meta-analysis compared all combinations
of open, minimally invasive and robotic approaches to
transthoracic oesophagectomy. The analysis demonstrated
that minimally invasive surgery for oesophagectomy was
associated with increased operating time, but decreased
operative blood loss, fewer pulmonary complications
and shorter length of hospital stay, compared with open
approaches. In addition, the review identified significantly
decreased overall postoperative complications with mini-
mally invasive surgery compared with the open approach.
Importantly, no significant differences in perioperative
mortality (either 30 or 90 day) were observed between any
surgical approach. In addition, MIO and RAMIO were
associated with significantly higher 1- and 5-year survival
rates respectively than open oesophagectomy. These find-
ings were not altered in a sensitivity analysis including
studies from 2010 onwards. Based on the present evidence,
no one approach demonstrates clear overall superiority
over all others, but there is increasing evidence of the
specific benefits related to minimally invasive techniques.
Network meta-analysis allows assessment of different
surgical techniques by combining direct evidence within
studies and indirect evidence across studies. Hence, it
enables indirect comparisons of surgical techniques that
have not been studied directly in a head-to-head fashion130.
By including evidence from both direct and indirect
comparisons, a network meta-analysis may increase the
precision in estimates of the relative effects of treatments
and improve power compared with standard pairwise
meta-analyses that include only direct evidence131. Net-
work meta-analysis may yield more reliable and definitive
results, and allows visualization and interpretation of a
wider picture of the available evidence, and to calculate
treatment rankings with probabilities, compared with a
standard pairwise meta-analysis130.
This study has some limitations. The majority of the
studies included in this network meta-analysis subject it
to heterogeneity owing to patient selection criteria and
demographics, such as age, sex, BMI and different dis-
ease stages. The amount of evidence a treatment carries
and the number of comparisons available between treat-
ments determines the diversity and strength of a net-
work meta-analysis. Imbalance in terms of the amount
of evidence available may affect the power and reliabil-
ity of the network meta-analysis as inferences may be
driven largely from the evidence from few treatments and
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comparisons132. Some of the studies assessed new tech-
niques or technologies and may have incorporated a learn-
ing curve in the novel arm.
Previous standard pairwise meta-analyses8–18 and
RCTs6,7,34,35 comparing open versus minimally inva-
sive resection for oesophagectomy demonstrated that,
although laparoscopic surgery increased operative time,
it resulted in significantly reduced blood loss and wound
infection, increased R0 resection rate and shorter hospital
stay. In addition, the present review identified significantly
decreased overall postoperative complications with mini-
mal access compared with open surgery, and this may be
related to the lower wound infection rate and pulmonary
complications of the minimally invasive approach.
This network meta-analysis identified that minimally
invasive surgery was associated with significantly more
examined lymph nodes compared with open surgery,
specifically with RAMIO and MIO techniques. Evidence
from RCTs6,7 is limited as none have demonstrated the
superiority of either laparoscopic or open techniques.
This network meta-analysis also showed that rates of R0
resection were better with MIO compared with open
surgery. This is an important point as one of the barriers
to adoption of the minimally invasive approach in routine
clinical practice over conventional open oesophagectomy
was concern over oncological clearance as R0 resections
are recognized to be an important prognostic marker
of long-term survival following surgery133,134. It is also
important to note that differences in R0 resection rates
may also be attributed to differences in the R0 classification
systems used.
Both RAMIO and MIO techniques were associated with
significantly lower rates of pulmonary complications and
shorter length of hospital stay compared with conventional
open oesophagectomy. However, there were no significant
differences in outcomes between robotic and conventional
MIO techniques. No significant differences between MIO
and open techniques in rates of wound or diaphragm com-
plications, gastrointestinal complications and chyle leak
were identified. Operative blood loss is difficult to mea-
sure accurately, and the clinical relevance of the small
differences in operative blood loss between the surgical
techniques is debatable. However, previous studies135–137
have suggested that volume of blood loss is an indepen-
dent risk factor for postoperative adverse events, cancer
recurrence and poorer overall survival. Furthermore, the
potential advantages of the MIO approach, and especially
the robotic approach, in decreasing operative trauma and
blood loss, and improving postoperative recovery, may
allow greater preservation of immune function, reduce the
risk of tumour progression and allow earlier access to adju-
vant treatment138–143.
A recent meta-analysis18 reported that minimally invasive
approaches for oesophagectomy significantly improved
long-term survival of patients compared with conventional
open surgery. However, that review did not address the
impact of the different techniques on long-term outcomes
given the heterogeneity of each approach as identified by
the present review. In this network meta-analysis, TAO and
MIO were only associated with a significant survival benefit
compared with open surgery at 1 year, and not 3- or 5-year
survival. This may reflect higher rates of negative resection
margins and number of lymph nodes examined with MIO
and RAMIO, as identified by this review.
Based on current evidence, no single approach demon-
strates clear overall superiority over all others, but there
is increasing evidence of the clinical benefits of minimally
invasive over open surgery.
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